Patent · US Active

Allergen desensitization method

US10272151B2 · kind B2 · utility

3Cited by

28References

14Claims

0Family size

Assignee

DBV TECHNOLOGIES · FR

Inventors

Christophe Dupont · Clamart, FR
Pierre-Henri Benhamou · Paris, FR
Bertrand Dupont · Aix-en-Provence, FR

Key dates

Filing date	Jul 16, 2018
Grant date	Apr 30, 2019
Priority date	—
Expiry date	Jul 16, 2038

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2039/545
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present application relates to a method for desensitization of allergic patients. More specifically it relates to an epicutaneous desensitization method, applicable to any type of allergens and of patients. The method of the invention is essentially non-invasive and does not require the use of adjuvants. Further, it may be easily applied and monitored by the actual patient.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.